Alzheimer Dementia (AD)
30
14
17
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 30 trials
100.0%
+13.4% vs benchmark
10%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (30)
Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
Low-Dose Radiotherapy for Alzheimer's Disease
Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression
Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
BCI With 40Hz Stimulation in Alzheimer's Disease
Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs
Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias
Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients (DetectAI)
Genetic Studies of Early-onset Dementia
Fisetin in Mild Alzheimer's Disease
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
Real World Outcomes of Intranasal MuSE Exosomes and Stem Cells in Neurological Regenerative Therapy
Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study
Making Antibody Treatments More Effective in Early Alzheimer's Disease Using 3Tesla Magnetica Resonance
Dementia and Storytelling in Vietnam
LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome
A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers.
Positive Psychology for Early Cognitive Decline: Effects on Cognitive and Brain Function
Combined Brain Stimulation and Methylphenidate Treatment for Apathy in Dementia
Transcranial Pulse Stimulation for Alzheimer's Disease